搜索筛选:
搜索耗时0.8084秒,为你在为你在102,267,441篇论文里面共找到 18 篇相符的论文内容
发布年度:
[期刊论文] 作者：Yunchao Huang,Ting Wang,
来源：医学科学进展杂志(英文) 年份：2020
Objective:To study the M receptor blocker on inhalation in patients with overlap syndrome(chronic obstructive pulmonary disease and Obstructive sleep apnea synd...
[期刊论文] 作者：Kun Wang Yunchao Huang Anning,
来源：中国肿瘤临床：英文版 年份：2008
Introduction Extramedullary plasmacytoma(EMP)is an uncommon tumor that often develops outside the bone and arises from clonal proliferation of atypical plas...
[期刊论文] 作者：Kaiyun Yang Yunchao Huang Guan,
来源：中德临床肿瘤学杂志：英文版 年份：2010
在 Xuanwei 区域的开火煤的污染被考虑了是为女肺癌症的高发生的本地主要理智的目的。学习的目的是调查 PAH-DNA 的表示，并且探索在开火煤的污染的大数字之间的关系在 Xuanwei...
Effect of three suture lines on the proliferation and cell cycle of lung adenocarcinoma cell A549 in
[期刊论文] 作者：Lianhua Ye Yunchao Huang Qilin,
来源：中德临床肿瘤学杂志：英文版 年份：2011
客观房间和医药 biomaterial 的相互作用是重要因素之一影响医药 biomaterial 的临床的申请。这研究是调查三根缝术线怎么在 vitro 影响增长和肺腺癌房间 A549 的房间周期。，...
[期刊论文] 作者：Lianhua Ye,Yunchao Huang,Qilin,
来源：中德临床肿瘤学杂志（英文版） 年份：2004
Objective: The interaction of cell and medical biomaterial is one of the significant factors to affect clinical application of medical biomaterial. This researc...
[期刊论文] 作者：Kun Wang,Yunchao Huang,Anning,
来源：中国肿瘤临床（英文版） 年份：2008
IntroductionExtramedullary plasmacytoma (EMP) is an uncommon tumor that often develops outside the bone and arises from clonal proliferation of atypical plasma...
[期刊论文] 作者：CHEN Yunchao,HUANG Daozhong,LI,
来源：华中科技大学学报（医学）（英德文版） 年份：2004
To examine the role of ultrasound in gene delivery in vitro, three cells lines were exposed to the low-frequency ultrasound of varying intensities and for diffe...
[期刊论文] 作者：Fei Gao,Yunchao Huang,Lixia Li,
来源：临床肿瘤与癌症研究：英文版 年份：2009
OBJECTIVE To explore the application of blocking the unilateralmain pulmonary artery (MPA) in pulmonary lobectomy (PL) forpatients with stage Ⅱ and Ⅲ lun...
[期刊论文] 作者：Fei Gao,Yunchao Huang,Lixia Li,
来源：临床肿瘤与癌症研究(英文版) 年份：2009
OBJECTIVE To explore the application of blocking the unilateral main pulmonary artery (MPA) in pulmonary lobectomy (PL) for patients with stage Ⅱand Ⅲ lung ca...
[期刊论文] 作者：Ping Zhao,Dewei Jiang,Yunchao Huang,Ceshi Chen,
来源：遗传学报 年份：2021
Ephrin type-A receptor 2 (EphA2),a receptor tyrosine kinase,is overexpressed in human breast cancers often linked to poor patient prognosis.Accumulating evidenc...
[期刊论文] 作者：Hualiang Lin,Bofu Ning,Jihua Li,Guangqiang Zhao,Yunchao Huang,Linwei Tian,
来源：医学前沿 年份：2015
...
[期刊论文] 作者：Yongchun Zhou,Yunlan Chen,Yunchao Huang,Guangqiang Zhao,Qian Yao,Lianhua Ye,Yaqian Du,,
来源：广西医科大学学报 年份：2016
...
[期刊论文] 作者：Xinchun Zhao,Yongchun Zhou,Qian Hu,Sanhui Gao,Jie Liu,Hong Yu,Yanfei Zhang,Guizhen Wang,Yunchao Huang,
来源：癌症生物学与医学（英文版） 年份：2020
Objective:Oncogenes have been shown to be drivers of non-small cell lung cancer (NSCLC),yet the tumor suppressing genes involved in lung carcinogenesis remain t...
[期刊论文] 作者：Yongchun Zhou,Yunlan Chen,Yunchao Huang,Guangqiang Zhao,QianYao,Lianhua Ye,Yaqian Du,Yanlong Yang,Quan,
来源：广西医科大学学报 年份：2016
Objective:To investigate the expression level of sex-determining region Y-related high mobility group box 4(Sox4)in female lung cancer patients and its clinical...
Overall survival (OS) with afatinib (A) vs gemcitabine/cisplatin (GC) in treatment-naive Chinese pat
[会议论文] 作者：Yi-Long Wu,Caicun Zhou,Cheng-Ping Hu,Jifeng Feng,Shun Lu,Yunchao Huang,Wei Li,Mei Hou,Jianhua Shi,Dan,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
Overall survival (OS) with afatinib (A) vs gemcitabine/cisplatin (GC) in treatment-naive Chinese pat
[会议论文] 作者：Yi-Long Wu,Caicun Zhou,Cheng-Ping Hu,Jifeng Feng,Shun Lu,Yunchao Huang,Wei Li,Mei Hou,Jianhua Shi,Dan,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective:A, an oral, irreversible ErbB family blocker, was compared with GC in 364 Asian pts with EGFR mut positive NSCLC, including 327 pts from China.PFS was significantly prolonged with A vs GC in...
LUX-Lung 6: A randomized, open-label, Phase Ⅲ study of afatinib vs.gemcitabine/cisplatin as first-li
[会议论文] 作者：Yi-Long Wu,Sarayut L Geater,Cheng-Ping Hu,Jifeng Feng,Shun Lu,Yunchao Huang,Wei Li,Jian Hua Shi,Mei Hou,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
...
LUX-Lung 6: A randomized, open-label, Phase Ⅲ study of afatinib vs.gemcitabine/cisplatin as first-li
[会议论文] 作者：Yi-Long Wu,Sarayut L Geater,Cheng-Ping Hu,Jifeng Feng,Shun Lu,Yunchao Huang,Wei Li,Jian Hua Shi,Mei Hou,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
Background: Afatinib is an oral, irreversible, ErbB Family Blocker, blocking signaling from EGFR (ErbB1), HER2 (ErbB2) and ErbB4.Afatinib was superior to first-line pemetrexed/cisplatin in terms of pr...
相关搜索：
